We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 29 JUNE 2011
Supreme Court Decision Alert - June 23, 2011

Mayer Brown
Contributor

Mayer Brown
Mayer Brown is a leading international law firm positioned to represent the world’s major...
View firm profileIn a trilogy of closely watched cases, "PLIVA, Inc. v. Mensing", No. 09-993, "Activas Elizabeth, LLC v. Mensing", No. 09-1039, and "Activas, Inc. v. Demahy", No. 09-1501, the Supreme Court held today that the federal statutes and regulations governing the labeling of generic drugs preempt state-law failure-to-warn claims against generic drug manufacturers.
United StatesLitigation, Mediation & Arbitration





